| Literature DB >> 28848764 |
Daofang Zhu1, Xianming Dou1, Liang Tang1, Dongdong Tang1, Guiyi Liao1, Weihua Fang1, Xiansheng Zhang1.
Abstract
Premature ejaculation (PE) is one of the most common sexual dysfunctions, which were associated with prostatitis-like symptoms (PLS). We intended to explore the prevalence of prostatitis-like symptoms and outcomes of National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) scores in outpatients with lifelong (LPE) and acquired premature ejaculation (APE). From December 2013 to December 2015, a total of 498 consecutive heterosexual men with PE and 322 male healthy subjects without PE were enrolled. Each of them completed a detailed questionnaire on demographics information, sexual and medical histories, and the NIH-CPSI. Assessment of NIH-CPSI and definition of PLS and PE were used to measure the PLS and NIH-CPSI scores and ejaculatory function for all subjects. Finally, a total of 820 subjects (including 498 men in PE group and 322 men in control group) were enrolled in our study. The mean ages were significantly different between PE and no PE groups. Men with PE reported worse PLS and higher NIH-CPSI scores (P < 0.001 for all). Similar findings were also observed between men with LPE and APE. Men with APE also reported higher rates of PLS and scores of NIH-CPSI (P < 0.001 for all). Multivariate analysis showed that PLS and NIH-CPSI scores were significantly associated with PE.Entities:
Mesh:
Year: 2017 PMID: 28848764 PMCID: PMC5564062 DOI: 10.1155/2017/3473796
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Outcomes of PLS and NIH-CPSI in men with LPE/APE.
| ALL ( | PE group ( | No PE group ( |
| LPE ( | APE ( |
| |
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Mild (4–7) | 134 (16.34%) | 102 (20.48%) | 32 (9.94%) | 23 (16.20%) | 79 (22.19%) | ||
| Moderate or severe (≥8) | 91 (11.10%) | 80 (16.06%) | 11 (3.42%) | 18 (12.68%) | 62 (17.42%) | ||
|
| |||||||
| Total scores | 19.74 ± 6.85 | 30.75 ± 8.89 | 2.72 ± 1.08 |
| 24.47 ± 8.44 | 33.26 ± 9.21 |
|
| Pain symptoms | 10.44 ± 4.32 | 16.44 ± 5.64 | 1.15 ± 0.41 |
| 14.46 ± 5.04 | 17.23 ± 6.12 |
|
| Urinary symptoms | 4.92 ± 1.88 | 7.43 ± 3.06 | 1.03 ± 0.40 |
| 5.27 ± 2.85 | 8.29 ± 3.33 |
|
| Quality of life impact | 4.37 ± 1.74 | 6.85 ± 2.16 | 0.54 ± 0.16 |
| 4.74 ± 1.45 | 7.74 ± 2.36 |
|
|
|
|
| |||||
| Mild (0–14) | 622 (75.85%) | 314 (63.05%) | 308 (95.65%) | 98 (69.01%) | 216 (60.67%) | ||
| Moderate (15–30) | 142 (17.32%) | 128 (25.70%) | 14 (4.35%) | 32 (22.54%) | 96 (26.97%) | ||
| Severe (31–43) | 56 (6.83%) | 56 (11.24%) | 0 (0.00%) | 12 (8.45%) | 44 (12.36%) |
PE = premature ejaculation; LPE = lifelong PE; APE = acquired PE; PLS = prostatitis-like symptoms; NIH-CPSI = National Institute of Health-Chronic Prostatitis Symptoms Index. Differences between PE and no PE groups were assessed by t-test. Differences between LPE and APE were assessed by t-test.
Demographic characteristics in men with and without PE.
| Factors | ALL ( | PE group ( | No PE group ( |
| LPE ( | APE ( |
|
|---|---|---|---|---|---|---|---|
|
| 39.21 ± 9.25 | 43.41 ± 9.45 | 32.72 ± 8.86 |
| 38.72 ± 9.17 | 45.28 ± 10.83 |
|
|
| 25.06 ± 3.14 | 26.59 ± 3.47 | 22.69 ± 2.75 |
| 23.74 ± 3.82 | 27.73 ± 3.65 |
|
|
| 2.15 ± 1.28 | 1.49 ± 0.56 | 3.16 ± 1.49 |
| 0.84 ± 0.25 | 1.75 ± 0.76 |
|
|
| 487 (59.39%) | 336 (64.47%) | 151 (46.89%) |
| 76 (53.52%) | 260 (73.03%) |
|
|
| 347 (42.32%) | 184 (36.95%) | 163 (50.62%) |
| 66 (46.48%) | 118 (33.15%) |
|
|
|
|
| |||||
| Others | 117 (14.27%) | 67 (13.45%) | 50 (15.53%) | 20 (14.08%) | 47 (13.20%) | ||
| Primary education | 171 (20.85%) | 100 (20.08%) | 71 (22.05%) | 28 (19.72%) | 72 (20.22%) | ||
| High school | 330 (40.24%) | 202 (40.56%) | 128 (39.75%) | 57 (40.14%) | 145 (40.73%) | ||
| Higher education | 202 (24.63%) | 129 (25.90%) | 73 (22.67%) | 37 (26.06%) | 92 (25.84%) | ||
|
|
|
| |||||
| Student | 192 (23.41%) | 110 (22.09%) | 82 (25.47%) | 32 (22.54%) | 78 (21.91%) | ||
| Unemployed | 198 (24.15%) | 121 (24.30%) | 77 (23.91%) | 31 (21.83%) | 90 (25.28%) | ||
| Employed | 333 (40.61%) | 202 (40.56%) | 131 (40.68%) | 60 (42.25%) | 142 (39.89%) | ||
| Retired | 97 (11.83%) | 65 (13.05%) | 32 (9.94%) | 19 (13.38%) | 46 (12.92%) |
PE = premature ejaculation; BMI = body mass index; IELT = intravaginal ejaculatory latency time; LPE = lifelong PE; APE = acquired PE. Differences between PE complaint and no PE complaint were assessed by Chi-square test or t-test, as appropriate. Differences between LPE and APE were assessed by Chi-square test or t-test, as appropriate.
Association between PLS, NIH-CPSI scores, and PE.
| Factors |
| OR | 95% CI | |
|---|---|---|---|---|
| Lower | Upper | |||
|
| ||||
|
|
| |||
|
|
|
| 2.26 | 4.33 |
|
| ||||
|
|
|
| ||
|
|
|
| 1.43 | 2.65 |
|
|
|
| 2.45 | 4.52 |
PE = premature ejaculation; PLS = prostatitis-like symptoms; NIH-CPSI = National Institute of Health-Chronic Prostatitis Symptoms Index; OR = Odds Ratio; CI = Confidence Interval. Date were assessed by the multiple logistic regression, when adjusted by age, BMI scores, smoking, and exercise.